Trials / Completed
CompletedNCT04947891
The Establishment of the Integration of Surgery and Postoperative Intensive Recovery of Patients With CSM
The Establishment of the Integration of Posterior Approach Surgical Treatment and Postoperative Intensive Recovery Management of Patients With Degenerative Cervical Spine Myelopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 17 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management for CSM or OPLL patients, and verify its safety, practicability and reliability.
Detailed description
In order to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management, and verify its safety, practicability and reliability, this study enrolled 130 patients with CSM or OPLL undergoing C3-7 open-door laminoplasty. Patients are divided in two groups randomly. The study group has 80 patients, treated with postoperative intensive recovery management, and the control group has 50 patients. The data is collected preoperatively, at 3-month follow-up and 1-year follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intensive recovery management | Intensive recovery management includes 3 parts: (1) Preoperative analgesia and airway evaluation. (2) The protection and reconstruction of the musculo-ligamentous complex during the surgery, the safe intubation, and the local infiltration anesthesia during surgery. (3) Collar free, multimodal analgesia, airway management, and early recovery after surgery. |
Timeline
- Start date
- 2017-12-06
- Primary completion
- 2020-06-15
- Completion
- 2020-12-20
- First posted
- 2021-07-01
- Last updated
- 2021-07-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04947891. Inclusion in this directory is not an endorsement.